S. K. Rudolph

发表

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.

P. A. Harris, J. Veal, Rakesh Kumar, 2008, Journal of medicinal chemistry.

High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size.

L. Kuyper, D. Baccanari, H. Friedman, 1996, Journal of medicinal chemistry.

INHIBITORS OF DIHYDROFOLATE REDUCTASE : DESIGN, SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF 2,4-DIAMINO-6-METHYL-5-ETHYNYLPYRIMIDINES

L. Kuyper, D. Baccanari, S. K. Rudolph, 1999 .

High-Affinity Inhibitors of Dihydrofolate Reductase: Antimicrobial and Anticancer Activities of 7,8-Dialkyl-1,3-diaminopyrrolo(3,2-f) quinazolines with Small Molecular Size.

L. Kuyper, D. Baccanari, H. Friedman, 1996 .

Eltrombopag, but Not Romiplostim or Thrombopoietin, Inhibits Growth of Thrombopoietin Receptor Positive and Negative Human Leukemia Cell Lines

S. K. Rudolph, C. Erickson-Miller, D. Rusnak, 2012 .

Immunogenicity of Thrombopoietin Mimetic Peptide GW395058 in BALB/c Mice and New Zealand White Rabbits: Evaluation of the Potential for Thrombopoietin Neutralizing Antibody Production in Man

S. K. Rudolph, D. Weigl, J. Hutchins, 1999, Stem cells.

Synthesis of 1,3-diamino-7,8,9,10-tetrahydropyrido[3,2-f]-quinazolines. Inhibitors of Candida albicans dihydrofolate reductase as potential antifungal agents

L. Kuyper, D. Baccanari, S. K. Rudolph, 1997 .

Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines.

L. Kuyper, D. Baccanari, S. K. Rudolph, 1995, Journal of medicinal chemistry.

Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines

A. Martin, T. Gilmer, S. K. Rudolph, 2007, Cell proliferation.

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Ming-Chih Crouthamel, L. Harrington, T. Gilmer, 2007, Molecular Cancer Therapeutics.

Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase.

J. Veal, Liping Wang, R. Nolte, 2005, Bioorganic & medicinal chemistry letters.